Clinical Trial Technology Solutions

a better way to manage your clinical development

Meet goals and achieve higher quality data, reduced costs, and shortened study timelines with support from ERT.

5.2M+

Patients Enrolled

230K

Sites Supported

600+

Drug Approvals

15K

Trials Managed

a better way to manage your trials

Meet clinical development goals and achieve higher quality data, reduced costs, and shortened study timelines with support from ERT.

CARDIAC SAFETY SOLUTIONS

eCOA SOLUTIONS

RESPIRATORY SOLUTIONS

IMAGING SOLUTIONS

PATIENT ENGAGEMENT

REAL-TIME PERFORMANCE & RISK MANAGEMENT

BUSINESS INTELLIGENCE

THE ERT EXPERT PLATFORM

Deliver Your Vaccine Trials. Faster.

ERT speeds up your vaccine clinical studies, capturing patient data quickly and accurately with its dedicated vaccines ePRO solution.

LEARN ABOUT VACCINES

MINIMIZE RISK AND UNCERTAINTY

We deliver the flexibility and adaptability you need to overcome challenges for faster speed to market. Here’s how:

EXPERTS IN COMPLEXITY

Supported 600+ new drug approvals

Helping you succeed at any level of complexity is our goal. We take what we’ve learned over decades as a leading provider of data and technology solutions and apply it to your clinical trial.

ADAPTIVE PROBLEM SOLVING

230k investigative sites supported

Every trial runs into unexpected challenges. With more than 15,000 trials under our belt, we’ve seen them before and have the expertise to put your trial back on course with our predictive analytics.

ANTICIPATORY OVERSIGHT

25 ready-to-launch analytics tools

We protect your trial before there’s ever an issue, ensuring its success through near real-time access to study, program and enterprise-level performance.

NEWS & EVENTS

Oncology Trials during the COVID-19 Pandemic: Using Virtual Trial Technology to Keep Patients Safe

Proven virtual trial technologies offer a solution to the many challenges clinical trial sponsors and CROs are facing,. Learn how they can be especially valuable in oncology trials, where limiting patients’ exposure to COVID-19 has become an important objective in the current era of clinical development.

Virtual Trials: The Silver Lining of the COVID-19 Pandemic

Learn the significant advantages of virtual trial elements in clinical development programs and how patients, sites, and sponsors are benefitting from this silver lining to the COVID-19 Pandemic.

ERT Survey Indicates Swift Adoption of Virtual Clinical Trials Due to COVID-19

82% respond that they are implementing elements of virtual trials due to the pandemic

Request A Quote